论文部分内容阅读
目的分析奥扎格雷钠治疗急性脑梗死的疗效。方法回顾性分析本院于2008年2月至2012年5月收治的102例急性脑梗死患者的临床资料,将患者随机分为观察组和对照组,其中观察组62例(常规治疗基础上给予奥扎格雷钠疗),对照组40例(常规治疗基础上给予复方丹参注射液治疗),分析2组的临床效果,并进行统计。结果观察组与对照组的治愈率分别为67.7%、15%,观察组与对照组的总有效率分别为100%、70%。对照组显著小于观察组;同时神经功能评分状况观察组显著优于观察组,差异具有统计学意义(P<0.05)。结论奥扎格雷钠对于治疗急性脑梗死疗效显著,能有效改善患者的神经功能等,安全有效,值得进一步向临床推荐。
Objective To analyze the efficacy of ozagrel sodium in the treatment of acute cerebral infarction. Methods The clinical data of 102 patients with acute cerebral infarction who were admitted to our hospital from February 2008 to May 2012 were retrospectively analyzed. The patients were randomly divided into observation group and control group, of which 62 patients in observation group (on the basis of routine treatment Ozagrel sodium treatment), 40 cases of control group (conventional treatment given compound Salvia injection treatment), the clinical effects of the two groups were analyzed and statistically. Results The cure rates of the observation group and the control group were 67.7% and 15% respectively, and the total effective rates of the observation group and the control group were 100% and 70% respectively. The control group was significantly smaller than the observation group; at the same time, the neurological function score observation group was significantly better than the observation group, the difference was statistically significant (P <0.05). Conclusion Ozagrel sodium is effective in treating acute cerebral infarction and can effectively improve the neurological function of patients. It is safe and effective and should be further recommended to the clinic.